Cargando...
Fatal COVID-19 in an MS patient on natalizumab: A case report
We report a fatal case of COVID-19 in a 51-year-old African American woman with multiple sclerosis on natalizumab. She had multiple risk factors for severe COVID-19 disease including race, obesity, hypertension, and elevated inflammatory markers, but the contribution of natalizumab to her poor outco...
Gardado en:
| Publicado en: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425275/ https://ncbi.nlm.nih.gov/pubmed/32850133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320942931 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|